Is there a role for pembrolizumab beyond progression in urothelial carcinoma?

BJU Int. 2023 Dec 10. doi: 10.1111/bju.16245. Online ahead of print.

Authors

Satoru Taguchi¹, Taketo Kawai², Tohru Nakagawa², Haruki Kume¹

Affiliations

¹ Department of Urology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
² Department of Urology, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan.

PMID: 38073020
DOI: 10.1111/bju.16245

No abstract available

Publication types

Editorial